5 Stocks Advancing The Health Services Industry

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 84 points (-0.5%) at 15,367 as of Wednesday, Aug. 14, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,073 issues advancing vs. 1,847 declining with 114 unchanged.

The Health Services industry currently is unchanged today versus the S&P 500, which is down 0.3%. Top gainers within the industry include Alere ( ALR), up 2.6%, Medtronic ( MDT), up 0.7% and Fresenius Medical Care AG & Co. KGaA ( FMS), up 0.5%. On the negative front, top decliners within the industry include Mindray Medical International ( MR), down 2.0%, Agilent Technologies ( A), down 0.9% and Aetna ( AET), down 0.7%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. Laboratory Corporation of America Holdings ( LH) is one of the companies pushing the Health Services industry higher today. As of noon trading, Laboratory Corporation of America Holdings is up $0.80 (0.8%) to $99.00 on average volume. Thus far, 315,718 shares of Laboratory Corporation of America Holdings exchanged hands as compared to its average daily volume of 739,900 shares. The stock has ranged in price between $98.01-$99.06 after having opened the day at $98.25 as compared to the previous trading day's close of $98.20.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. Laboratory Corporation of America Holdings has a market cap of $8.8 billion and is part of the health care sector. Shares are up 13.4% year to date as of the close of trading on Tuesday. Currently there is 1 analyst that rates Laboratory Corporation of America Holdings a buy, 2 analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates Laboratory Corporation of America Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in stock price during the past year, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Laboratory Corporation of America Holdings Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Quest Diagnostics ( DGX) is up $0.46 (0.8%) to $59.97 on average volume. Thus far, 599,126 shares of Quest Diagnostics exchanged hands as compared to its average daily volume of 1.3 million shares. The stock has ranged in price between $59.36-$59.99 after having opened the day at $59.36 as compared to the previous trading day's close of $59.51.

Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. Quest Diagnostics has a market cap of $9.0 billion and is part of the health care sector. Shares are up 2.1% year to date as of the close of trading on Tuesday. Currently there are 2 analysts that rate Quest Diagnostics a buy, 3 analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Quest Diagnostics as a buy. The company's strengths can be seen in multiple areas, such as its expanding profit margins, largely solid financial position with reasonable debt levels by most measures, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Quest Diagnostics Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Edwards Life ( EW) is up $0.79 (1.1%) to $72.81 on light volume. Thus far, 203,417 shares of Edwards Life exchanged hands as compared to its average daily volume of 1.2 million shares. The stock has ranged in price between $71.95-$72.99 after having opened the day at $71.95 as compared to the previous trading day's close of $72.02.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Life has a market cap of $8.1 billion and is part of the health care sector. Shares are down 19.8% year to date as of the close of trading on Tuesday. Currently there are 9 analysts that rate Edwards Life a buy, no analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Edwards Life as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Edwards Life Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, DaVita HealthCare Partners ( DVA) is up $0.61 (0.5%) to $115.26 on light volume. Thus far, 231,941 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 851,700 shares. The stock has ranged in price between $114.36-$115.66 after having opened the day at $114.70 as compared to the previous trading day's close of $114.65.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $12.2 billion and is part of the health care sector. Shares are up 3.8% year to date as of the close of trading on Tuesday. Currently there are 7 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share, increase in net income, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full DaVita HealthCare Partners Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, HCA Holdings ( HCA) is up $0.76 (2.0%) to $39.39 on light volume. Thus far, 1.2 million shares of HCA Holdings exchanged hands as compared to its average daily volume of 3.7 million shares. The stock has ranged in price between $38.71-$39.50 after having opened the day at $38.82 as compared to the previous trading day's close of $38.63.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. HCA Holdings has a market cap of $17.3 billion and is part of the health care sector. Shares are up 28.0% year to date as of the close of trading on Tuesday. Currently there are 13 analysts that rate HCA Holdings a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates HCA Holdings as a sell. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow and feeble growth in its earnings per share. Get the full HCA Holdings Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Stocks Trade Mixed Amid Progress on U.S.-China Trade; Dow Turns Lower

Stocks Trade Mixed Amid Progress on U.S.-China Trade; Dow Turns Lower

Micron Spikes After $10 Billion Buyback Plan Caps Bullish Q3 Earnings Forecast

Micron Spikes After $10 Billion Buyback Plan Caps Bullish Q3 Earnings Forecast

J.C. Penney Shares Fall as CEO Marvin Ellison Resigns to Head Lowe's

J.C. Penney Shares Fall as CEO Marvin Ellison Resigns to Head Lowe's

U.S. Crude Oil Hits Fresh 3-Year Highs as Gas Prices March to $3 a Gallon

U.S. Crude Oil Hits Fresh 3-Year Highs as Gas Prices March to $3 a Gallon

Oil Prices, China Tariffs, Micron and Kohl's - 5 Things You Must Know

Oil Prices, China Tariffs, Micron and Kohl's - 5 Things You Must Know